Barinthus Biotherapeutics PLBRNS
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 19 institutions reported holding Barinthus Biotherapeutics PL (BRNS) in their 13F filings, up 1 from Q2 2024. 1 opened new positions and 1 sold out. The largest holders were M&G PLC ($5.2M), HSG Holding Ltd ($1.9M) and Alphabet Inc. ($1.8M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Barinthus Biotherapeutics PL
- CUSIP
- 91864C107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $12K |
| Exits | 1 | $6K |
All 13F filers, Q2 2024 → Q3 2024: 30,431 shares bought and 265,030 shares sold, net −234,599 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| M&G PLC | 0.03% | No change | 5,197,349 | $5.2M |
| HSG Holding Ltd | 0.07% | No change | 1,420,473 | $1.9M |
| Alphabet Inc. | 0.10% | No change | 1,513,644 | $1.8M |
| DC Funds, LP | 14.84% | No change | 642,204 | $764K |
| BlueCrest Capital Management Ltd | 0.32% | No change | 542,673 | $646K |
| Johns Hopkins University | 0.01% | No change | 122,237 | $145K |
| Baird Financial Group, Inc. | 0.00% | Reduce -65.5% | 92,461 | $110K |
| Citadel Advisors | 0.00% | Add +72.8% | 27,717 | $34K |
| Renaissance Technologies | 0.00% | Add +11.2% | 27,900 | $33K |
| Ipswich Investment Management Co., Inc. | 0.01% | Reduce -2.2% | 22,575 | $27K |
| Catalina Capital Group, LLC | 0.01% | Add +15.1% | 20,512 | $24K |
| Janney Montgomery Scott LLC | 0.00% | No change | 15,008 | $18K |
| Morgan Stanley | 0.00% | Add +35.0% | 11,983 | $14K |
| Geode Capital Management, LLC | 0.00% | No change | 11,568 | $14K |
| Millennium Management | 0.00% | New | 10,148 | $12K |
| BlackRock, Inc. | 0.00% | — | 6,485 | $8K |
| UBS Group AG | 0.00% | Reduce -98.3% | 1,432 | $2K |
| New England Capital Financial Advisors LLC | 0.00% | No change | 104 | $124 |
| Rhumbline Advisers | 0.00% | No change | 60 | $73 |
"% of holder's portfolio" is BRNS's weight in each manager's 13F, not the share of Barinthus Biotherapeutics PL the manager owns.